Next Related Article for: Al Doyle

Recommending approval for Abbott Labs: ABT, CURE, EQTD, CIEN, STTC.

0 Comments | M2 Presswire, June, 2005

M2 PRESSWIRE-28 June 2005-InvestSource Inc.: Recommending approval for Abbott Labs: ABT, CURE, EQTD, CIEN, STTC(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:28062005 Stocks in the news: Abbott Labs (NYSE: ABT), Curative Health (NASDAQ: CURE), Company Equal Incorporated (OTB: EQTD), Ciena Corporation (NASDAQ: CIEN), SoftNet Technology Corporation (OTCBB: STTC) Abbott Labs (NYSE: ABT) company announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has issued a positive opinion recommending approval of Humira for the treatment of psoriatic arthritis.

The positive opinion for Humira as a treatment for psoriatic arthritis is based upon two placebo-controlled studies, including data from the...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)